CORT vs PTGX: stock comparison and AI forecast
Corcept Therapeutics Inc (CORT) and Protagonist Therapeutics, Inc (PTGX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CORT Corcept Therapeutics Inc
- Price
- $80.46 +55.9% · 6M
- Market Cap
- $8.70B
- P/E Ratio
- 90.4x
- Size
- mid-cap
- AI Forecast
PTGX Protagonist Therapeutics, Inc
- Price
- $139.37 +40.0% · 6M
- Market Cap
- $9.02B
- P/E Ratio
- 176.4x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- CORT and PTGX have similar market capitalizations ($8.70B and $9.02B).
- CORT trades at 90.4 times trailing earnings, PTGX at 176.4 times.
- Over the last six months CORT returned +55.9% and PTGX +40.0%.
- CORT carries 0.26 times debt per unit of equity, against 0.05 times for PTGX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CORT | PTGX |
|---|---|---|
| Market Cap | $8.70B | $9.02B |
| P/E Ratio | 90.40x | 176.41x |
| P/B Ratio | 12.32x | 10.72x |
| EPS | $0.89 | $0.79 |
| Book Value/Share | $6.53 | $13.01 |
| Revenue/Share | $6.16 | $3.49 |
| FCF/Share | $0.99 | $2.02 |
Profitability & Margins
| Metric | CORT | PTGX |
|---|---|---|
| ROE | 7.8% | – |
| ROA | 6.2% | – |
| ROIC | 0.9% | 6.9% |
| Gross Margin | 97.9% | – |
| Operating Margin | 1.0% | 25.9% |
| Net Margin | 8.3% | – |
| EBT Margin | 4.0% | 36.4% |
| Tax Rate | -109.3% | 1.7% |
Financial Health
| Metric | CORT | PTGX |
|---|---|---|
| Current Ratio | 2.86x | 21.71x |
| Quick Ratio | 2.77x | – |
| D/E Ratio | 0.26x | 0.05x |
| Financial Leverage | 1.26x | 1.05x |
| Working Capital | $286M | $770M |
Cash Flow
| Metric | CORT | PTGX |
|---|---|---|
| Operating Cash Flow | $110M | $131M |
| Free Cash Flow | $107M | $131M |
| Capital Spending | -$3M | -$610K |
| OCF Growth YoY | -39.8% | 231.8% |
| FCF Growth YoY | -40.7% | 252.0% |
| FCF/Sales | 16.1% | 57.9% |
| CapEx/Sales | 0.4% | 0.3% |
Operational Efficiency
| Metric | CORT | PTGX |
|---|---|---|
| Asset Turnover | 0.75x | 0.25x |
| Receivables Turnover | 8.7x | – |
| Inventory Turnover | 1.1x | – |
| Fixed Assets Turnover | 129.7x | 65.3x |
| Days Sales Outstanding | 42 days | – |
| Days Inventory | 342 days | – |
| Payables Period | 386 days | – |
| Cash Conversion Cycle | -3 days | – |
Income Statement
| Metric | CORT | PTGX |
|---|---|---|
| Total Revenue | $666M | $226M |
| Operating Income | $6M | $58M |
| Net Income | $55M | – |
| R&D Expense | $254M | $175M |
| SG&A Expense | $556M | – |
| Cost of Goods Sold | $14M | – |
Dividend & Shareholder Information
| Metric | CORT | PTGX |
|---|---|---|
| Shares Outstanding | 108M | 65M |
| Net Income Growth | -58.7% | – |
| EPS Growth | -25.8% | -14.1% |
CORT vs PTGX: stock comparison and AI forecast
Which is bigger, CORT or PTGX?
CORT and PTGX have similar market capitalizations ($8.70B and $9.02B).
Which is cheaper on earnings, CORT or PTGX?
CORT trades at 90.4 times trailing earnings, PTGX at 176.4 times.
Which stock performed better over the last six months, CORT or PTGX?
Over the last six months CORT returned +55.9% and PTGX +40.0%.
Which one does Intratio's AI model rank higher, CORT or PTGX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.